4.7 Article

Alantolactone inhibits cervical cancer progression by downregulating BMI1

Journal

SCIENTIFIC REPORTS
Volume 11, Issue 1, Pages -

Publisher

NATURE RESEARCH
DOI: 10.1038/s41598-021-87781-z

Keywords

-

Funding

  1. National Natural Science Foundation [81903005]
  2. Hubei Province Innovation Project of Science and Technology Cooperation with Foreign countries [2019AHB068]
  3. experimental animal resources development and utilization project of Hubei Province of China [2020DFE025]
  4. Science and Technology Development Project of Xiangyang
  5. Institute of Medicine and Nursing at Hubei University of Medicine [2017YHKT02]
  6. Scientific Research Project of Hubei Province Health Committee [ZY2019F028]

Ask authors/readers for more resources

This study highlights the significant role of BMI1 in cervical cancer, with high expression associated with poor differentiation, high clinical grade, and poor prognosis. Furthermore, alantolactone shows promising effects in reducing proliferation, migration, and invasion of cervical cancer cells, as well as promoting autophagy and mitochondrial damage.
Cervical cancer is the second most common cancer in women. Despite advances in cervical cancer therapy, tumor recurrence and metastasis remain the leading causes of mortality. High expression of BMI1 is significantly associated with poor tumor differentiation, high clinical grade, and poor prognosis of cervical cancer, and is an independent prognostic factor in cervical carcinoma. Alantolactone (AL), a sesquiterpene lactone, exhibits potent anti-inflammatory and anticancer activities. In this paper, we investigated the mechanism of AL in reducing the proliferation, migration, and invasion of HeLa and SiHa cervical cancer cells as well as its promotion of mitochondrial damage and autophagy. BMI1 silencing decreased epithelial-mesenchymal transformation-associated proteins and increased autophagy-associated proteins in HeLa cells. These effects were reversed by overexpression of BMI1 in HeLa cells. Thus, BMI1 expression is positively correlated with invasion and negatively correlated with autophagy in HeLa cells. Importantly, AL decreased the weight, volume, and BMI1 expression in HeLa xenograft tumors. Furthermore, the structure of BMI1 and target interaction of AL were virtually screened using the molecular docking program Autodock Vina; AL decreased the expression of N-cadherin, vimentin, and P62 and increased the expression of LC3B and Beclin-1 in xenograft tumors. Finally, expression of BMI1 increased the phosphorylation of STAT3, which is important for cell proliferation, survival, migration, and invasion. Therefore, we suggest that AL plays a pivotal role in inhibiting BMI1 in the tumorigenesis of cervical cancer and is a potential therapeutic agent for cervical cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available